近期论文
查看导师最新文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
Wang Y, Liu Y, Liu Y, Zhong J, Wang J, Sun L, Yu L, Wang Y, Li Q*, Jin W, Yan Z*. Remodeling liver microenvironment by L-arginine loaded hollow polydopamine nanoparticles for liver cirrhosis treatment. Biomaterials, 2023, 122028. (IF=15.305)
Sun L, Zhang J, Zhou JE, Wang J, Wang Z, Luo S, Wang Y, Zhu S*, Yang F, Tang J, Lu W, Wang Y, Yu L, and Yan Z*. Monitoring the in vivo siRNA release from lipid nanoparticles based on the fluorescence resonance energy transfer principle. Asian J Pharm Sci. 2023, 18: 100769. (IF = 9.273)
Sun L, Zhou J, Luo T, Wang J, Kang L, Wang Y, Luo S, Wang Z, Zhou Z, Zhu J, Yu J, Yu L, Yan Z*. Nanoengineered neutrophils as cellular sonosensitizer for visual sonodynamic therapy of malignant tumors. Adv. Mater., 2022, e2109969. (IF =32.086)
Zhou JE, Sun L, Jia Y, Wang Z, Luo T, Tan J, Fang X, Zhu H, Wang J, Yu L*, Yan Z*. Lipid nanoparticles produce chimeric antigen receptor T cells with interleukin-6 knockdown in vivo. J Control Release. 2022, 350: 298-307 (IF = 11.467)
Zhou JE, Sun L, Liu L, Jia Y, Han Y, Shao J, Wang J, Wang Y, Yu L, Yan Z*. Hepatic macrophage targeted siRNA lipid nanoparticles treat non-alcoholic steatohepatitis. J. Control. Release, 2022, 343: 175-186 (IF = 11.467)
Tan J, Jia Y, Zhou M, Fu C, Tuhin I J, Ye J, Monty M A, Xu N, Kang L, Li M, Shao J, Fang X, Zhu H, Yan L, Qu C, Xue S, Jin Z, Chen S, Huang H, Xu Y, Chen J, Miao M, Tang X, Li C, Yan Z*, Wu D*, Yu L*. Chimeric antigen receptors containing the OX40 signalling domain enhance the persistence of T cells even under repeated stimulation with multiple myeloma target cells. J. Hematol. Oncol., 2022, 15(1): 39 (IF = 23.168)
Wang Y, Liu Y, Zhou J-e, Lin L, Jia C, Wang J, Yu L, Wang Y*, Yan Z*. Controllable hydrogen release for gas-assisted chemotherapy and ultrasonic imaging of drug-resistant tumors. Chem. Eng. J., 2021, 421: 129917. (IF=16.744)
Zhang J, Shen H, Xu J, Liu L, Tan J, Li M, Xu N, Luo S, Wang J, Yang F, Tang J, Li Q, Wang Y, Yu L*, Yan Z*. Liver-Targeted siRNA Lipid Nanoparticles Treat Hepatic Cirrhosis by Dual Antifibrotic and Anti-inflammatory Activities. ACS Nano, 2020;14(5):6305-22. (IF=15.881)
Gao L, Yu J, Liu Y, Zhou J, Sun L, Wang J, Zhu J, Peng H, Lu W, Yu L, Yan Z*, Wang Y*. Tumor-penetrating Peptide Conjugated and Doxorubicin Loaded T1-T2 Dual Mode MRI Contrast Agents Nanoparticles for Tumor Theranostics. Theranostics, 2018, 7(20):4984-5000 (IF=8.537)
Fan M, Li M, Gao L, Geng S, Wang J, Wang Y, Yan Z*, Yu L*. Chimeric antigen receptors for adoptive T cell therapy in acute myeloid leukaemia. J Hematol Oncol, 2017, 10(1): 151. （IF=7.333）
Jia Z, Gong Y, Pi Y, Liu X, Gao L, Kang L, Wang J, Yang F, Tang J, Lu W, Li Q, Zhang W, Yan Z*, Yu L*. pPB peptide-mediated siRNA-loaded stable nucleic acid lipid nanoparticles on targeting therapy of hepatic fibrosis. Mol Pharm, 2018, 15(1): 53-62（IF=4.566）
Zhou JE, Yu J, Gao L, Sun L, Peng T, Wang J, Zhu J, Lu W, Zhang L, Yan Z*, Yu L*. iNGR-Modified Liposomes for Tumor Vascular Targeting and Tumor Tissue Penetrating Delivery in the Treatment of Glioblastoma. Mol Pharm, 2017, 14(5): 1811-1820.（IF=4.556）
Yan Z*, Yang Y, Wei X, Zhong J, Wei D, Liu L, Xie C, Wang F, Zhang L, Lu W*, He D. Tumor-penetrating Peptide mediation: an effective strategy for improving the transport of liposomes in tumor tissue. Mol Pharm, 2014, 11(1): 218-225.（IF=4.384）
杨一祎, 闫志强*, 钟建, 何丹农*, 陆伟跃, 多肽介导的肿瘤靶向纳米递药系统, 化学进展, 2013, 25(06):1052-1060.
Yan Z, Wang F, Wen Z, Zhan C, Feng L, Liu Y, Wei X, Xie C, Lu W*. LyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumor. J Control Release, 2012, 157(1): 118-125.（IF=7.633）
京公网安备 11010802027423号